Hederasal

Dry extract of Hederae folium (Der 4-8:1), the active ingredient in Hederasal, is a herbal botanical presented as a dry botanical extract for oral use. It is traditionally employed to support respiratory health and to alleviate cough in adults and children.

GNH USA supplies Hederasal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to meet global market requirements. Clients benefit from reliable delivery schedules and dedicated technical support throughout the procurement process.

Hederasal, containing ivy leaf extract, is used in the management of respiratory conditions that involve mucus accumulation and cough.

Cough (non‑productive): helps loosen and expel mucus, reducing cough frequency. Acute bronchitis: supports airway clearance and may shorten symptom duration. Upper respiratory tract infections: alleviates congestion and promotes easier breathing.

Oral administration of Hederasal may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: mild nausea or stomach upset. - Taste alteration: bitter or unusual taste in the mouth. - Dizziness: transient light‑headedness. - Skin irritation: mild rash or itching.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis requiring immediate medical attention. - Severe bronchospasm: paradoxical tightening of airways causing breathing difficulty. - Hepatic enzyme elevation: abnormal liver function tests observed in rare cases.

Before using Hederasal, consider the following safety measures to minimize risk.

Pregnancy: safety not established; avoid unless prescribed by a physician. Breastfeeding: use with caution as transfer to milk is unknown. Children: limit use to age groups recommended by healthcare professional. Concomitant anticoagulant therapy: monitor for increased bleeding tendency. Liver disease: assess hepatic function before initiation. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Hederasal may interact with other medicines; awareness of potential interactions helps ensure safe use.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may enhance bleeding risk. - Other expectorants or mucolytics: additive effect may cause excessive bronchial secretion.

Moderate Interactions (Monitor Closely): - Antihistamines: possible reduction in cough‑suppressant effect. - Bronchodilators: monitor respiratory response for synergistic action. - Diuretics: observe electrolyte balance as saponins may affect renal excretion.